Ortho-Clinical Diagnostics GMBH

Ortho-Clinical Diagnostics GMBH, operating through its Ortho Clinical Diagnostics Division, is a for-profit international organization headquartered in Cologne, Germany, specializing in the manufacturing and distribution of advanced diagnostic systems and medical supplies. The company has maintained continuous federal vendor registration since December 2003 and serves as a critical supplier of sophisticated medical diagnostic technologies to various U.S. federal healthcare agencies. Through its federal contracting relationships, Ortho-Clinical Diagnostics GMBH provides comprehensive diagnostic solutions that support both domestic and overseas military and veterans healthcare facilities.

Ortho-Clinical Diagnostics GMBH has demonstrated a consistent track record of delivering specialized medical diagnostic goods and services across multiple federal agencies without set-aside designations. The company's contract awards include the provision of Ortho-Vision Analyzer consumables to the Defense Health Agency in support of the Landstuhl Regional Medical Center in Germany, with multiple task orders valued between $178,000 and $179,000 under existing blanket purchase agreements. Additionally, the company has supplied Micro Typing System gel cards, chemistry analyzers with lease and maintenance services, and full-service analyzer support to the Defense Health Agency, with individual contract values ranging from approximately $135,000 to $184,000. The U.S. Army Medical Command has awarded the company blanket purchase agreement calls for decentralized diagnostic systems, including both annual calls and multi-year commitments valued at approximately $3,900 to $10,700. The Department of Veterans Affairs Veterans Health Administration awarded a definitive contract to Ortho-Clinical Diagnostics GMBH valued at $60,000 for maintenance services to be performed at a facility in Martinsburg, West Virginia, with completion scheduled for April 2029. All contract awards have been firm fixed price arrangements with performance primarily occurring in Germany, reflecting the company's position as a strategically important supplier for maintaining diagnostic testing operations at federal healthcare facilities.

Ortho-Clinical Diagnostics GMBH currently holds a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $1,200,000, effective from October 1, 2024, through September 30, 2029. This IDV covers the provision of consumables compatible with government-owned Ortho Vision Analyzers and represents the company's primary vehicle for delivering ongoing diagnostic supplies to federal healthcare systems. The BPA has already generated multiple task orders, including calls awarded in October 2025 for $178,231.76 in Ortho-Vision Analyzer consumables supporting the Landstuhl Regional Medical Center. The agreement demonstrates the Defense Health Agency's confidence in Ortho-Clinical Diagnostics GMBH as a trusted long-term partner for maintaining critical diagnostic capabilities across military healthcare facilities. Historical records indicate the company previously held additional blanket purchase agreements with the U.S. Army Medical Command valued at $2,000,000, though current active IDVs appear concentrated within the Defense Health Agency relationship. The company's IDV portfolio positions it to continue providing essential diagnostic consumables, reagents, and analyzer support services to federal agencies through established procurement vehicles rather than competitive task order competitions.